EX-FILING FEES 2 ea156494ex-fee_nlspharma.htm FILING FEE TABLE

Exhibit 107

 

Calculation of Filing Fee Tables

 

424(b)(5)

(Form Type)

 

NLS Pharmaceutics Ltd.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

                                                 
                         
    Security
Type
  Security Class Title   Fee
Calculation
or Carry
Forward
Rule
  Amount
Registered
  Proposed
Maximum
Offering
Price Per
Unit
  Maximum
Aggregate
Offering Price
 

Fee

Rate

 

Amount of

Registration
Fee

  Carry
Forward
Form
Type
 

Carry
Forward

File
Number

  Carry
Forward
Initial
Effective
Date
  Filing Fee
Previously
Paid In
Connection
with Unsold
Securities to
be Carried
Forward
 
Newly Registered Securities
                         

Fees to Be

Paid

  Equity   Common shares, par value CHF 0.02   457(o)   (1)   (1)   $3,900,000   $0.0000927   $361.53                
                         
Fees Previously Paid   Equity   Common shares, par value CHF 0.02   (2)   (2)   (2)   $75,000,000   (2)   $6,925.50                
 
Carry Forward Securities
                         
Carry Forward Securities                                                
                   
    Total Offering Amounts       $3,900,000       $361.53                
                   
    Total Fees Previously Paid               $6,925.50                
                   
    Total Fee Offsets               -                
                   
    Net Fee Due               $0                

 

(1)

Consists of up to $3,900,000 of common shares, par value CHF 0.02, of NLS Pharmaceutics Ltd. (the “Company”) issuable pursuant to the ATM Sales Agreement, dated as of March 4, 2022 (the “Agreement”), by and between the Company and Virtu Americas LLC.

 

 

(2)

Relates to the shelf registration statement on Form F-3 filed by the Company for the sale of up to $75,000,000 of the Company’s securities, which was declared effective by the Securities and Exchange Commission on February 11, 2022, pursuant to which the Company paid a registration fee of $6,925.50. Such prior registration fee was estimated solely to calculate the registration fee in accordance with Rule 457(o), based on the proposed maximum aggregate offering price, under the Securities Act of 1933, as amended.